Korea United Pharm Inc
KRX:033270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Korea United Pharm Inc
Tax Provision
Korea United Pharm Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Korea United Pharm Inc
KRX:033270
|
Tax Provision
-₩11.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
|
Yuhan Corp
KRX:000100
|
Tax Provision
-₩37.4B
|
CAGR 3-Years
-105%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Tax Provision
₩102.4B
|
CAGR 3-Years
223%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Tax Provision
-₩26.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
6%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Tax Provision
-₩487.7m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
44%
|
CAGR 10-Years
17%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Tax Provision
-₩2.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Korea United Pharm Inc
Glance View
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Korea United Pharm Inc's Tax Provision?
Tax Provision
-11.6B
KRW
Based on the financial report for Sep 30, 2025, Korea United Pharm Inc's Tax Provision amounts to -11.6B KRW.
What is Korea United Pharm Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-8%
Over the last year, the Tax Provision growth was -5%. The average annual Tax Provision growth rates for Korea United Pharm Inc have been 9% over the past three years , -2% over the past five years , and -8% over the past ten years .
